Table 2 |
|||
|
The incidence and severity of arthritis after intra-articular injection of 100 µg peptidoglycan to SCID mice depleted of neutrophils and monocytes |
|||
|
Number |
|||
|
Group |
of mice |
Incidence (%) |
Severity |
|
|
|||
|
CB17 |
10 |
100 |
2.8 ± 0.4 |
|
SCID + RB6-8C5 |
10 |
100 |
1.6 ± 0.5 |
|
SCID +etoposide |
8 |
50 |
0.5 ± 0.5 |
|
SCID+ RB6-8C5 + |
8 |
50 |
0.6 ± 0.7 |
|
etoposide |
|||
|
BALB/c+RB6-8C5 + |
10 |
70 |
1.5 ± 1.1 |
|
etoposide |
|||
|
|
|||
|
Liu et al. Arthritis Res 2001 3:375 doi:10.1186/ar330 |
|||
